- Home
- ATNM vs MIND Comparison
ATNM vs MIND Comparison
Compare ATNM & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- MIND
- Stock Information
- Founded
- ATNM 2000
- MIND 1987
- Country
- ATNM United States
- MIND United States
- Employees
- ATNM N/A
- MIND N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- MIND Industrial Machinery/Components
- Sector
- ATNM Health Care
- MIND Industrials
- Exchange
- ATNM Nasdaq
- MIND Nasdaq
- Market Cap
- ATNM 51.5M
- MIND 49.6M
- IPO Year
- ATNM N/A
- MIND 1994
- Fundamental
- Price
- ATNM $1.47
- MIND $7.86
- Analyst Decision
- ATNM Strong Buy
- MIND
- Analyst Count
- ATNM 3
- MIND 0
- Target Price
- ATNM $4.67
- MIND N/A
- AVG Volume (30 Days)
- ATNM 518.4K
- MIND 519.0K
- Earning Date
- ATNM 08-04-2025
- MIND 06-10-2025
- Dividend Yield
- ATNM N/A
- MIND N/A
- EPS Growth
- ATNM N/A
- MIND N/A
- EPS
- ATNM N/A
- MIND 2.91
- Revenue
- ATNM N/A
- MIND $45,087,000.00
- Revenue This Year
- ATNM N/A
- MIND $7.27
- Revenue Next Year
- ATNM N/A
- MIND N/A
- P/E Ratio
- ATNM N/A
- MIND $2.79
- Revenue Growth
- ATNM N/A
- MIND 26.68
- 52 Week Low
- ATNM $1.03
- MIND $3.05
- 52 Week High
- ATNM $8.64
- MIND $11.10
- Technical
- Relative Strength Index (RSI)
- ATNM 44.59
- MIND 59.57
- Support Level
- ATNM $1.41
- MIND $8.34
- Resistance Level
- ATNM $1.49
- MIND $8.85
- Average True Range (ATR)
- ATNM 0.12
- MIND 0.65
- MACD
- ATNM -0.02
- MIND 0.10
- Stochastic Oscillator
- ATNM 25.00
- MIND 64.53
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.